Daniel P. Schultze
Heidelberg, BW 69120, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Glycine protects partial liver grafts from Kupffer cell-dependent ischemia-reperfusion injury without negative effect on regeneration.
Journal: Amino acids
Published: February 12, 2019
N-acetylcysteine protects hepatocytes from hypoxia-related cell injury.
Journal: Clinical and experimental hepatology
Published: February 20, 2018
Glycine Protects the Liver from Reperfusion Injury following Pneumoperitoneum.
Journal: European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes
Published: December 05, 2017
Use of a hydrophilic coating wire reduces significantly the rate of central vein punctures and the incidence of pneumothorax in totally implantable access port (TIAP) surgery.
Journal: BMC surgery
Published: July 16, 2017
Impact of Inter-Laboratory Variability on Model of End-Stage Liver Disease (MELD) Score Calculation.
Impact of Inter-Laboratory Variability on Model of End-Stage Liver Disease (MELD) Score Calculation.
Journal: Annals of transplantation
Published: November 02, 2016
Glycine inhibits angiogenesis in colorectal cancer: role of endothelial cells.
Journal: Amino acids
Published: October 07, 2015
Early markers of reperfusion injury after liver transplantation: association with primary dysfunction.
Journal: Hepatobiliary & pancreatic diseases international : HBPD INT
Published: June 12, 2015
A systematic review of pharmacological treatment options used to reduce ischemia reperfusion injury in rat liver transplantation.
Journal: PloS one
Published: November 07, 2014
Prediction of postoperative mortality in liver transplantation in the era of MELD-based liver allocation: a multivariate analysis.
Journal: PloS one
Published: February 02, 2014
Glycine inhibits angiogenic signaling in human hepatocellular carcinoma cells.
Journal: Amino acids
Published: September 15, 2013
Therapeutic potential and adverse events of everolimus for treatment of hepatocellular carcinoma - systematic review and meta-analysis.
Journal: Cancer medicine
Published: April 18, 2013
Last Updated: 09/26/2026